bpc-157 oral bioavailability pharmacokinetics studies BPC 157 Dosage: A Doctor's Evidence-Based Guide Pharmacokinetics, distribution, metabolism, and excretion – BPC-157 Oral vs Injection: Benefits,

It promotes tissue repair, cell migration, and angiogenesis

I strongly recommend the recent reporting by Undark if you want the full rundown

BPC-157 consistently upregulates VEGF in preclinical models, building the vascular network that increases oxygen and nutrient delivery to the repair site

Protocol Details: Dose 500 mcg / 1 mg (10 units on 1ml insulin syringe) Timing AM Frequency 5 days on, 2 days off Duration 8 weeks on, 8 weeks off Administration SubQ injection Source Jays Note: If you want to simplify the injectable side of this protocol down to one shot, the Metabolic Blend is the cleanest way to do it